Early triple-negative breast cancer
1 paper
- Humans1
Trial sponsors
Russian Academy of Medical Sciences
1 trialPhase 241 people
Latest
Science Translational Medicine
Interferon-induced senescent CD8⁺ T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer
Cohort study of 171 peopleBlood and immune system